Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Monday, May 25, 2026
Comment
Sun Pharma has been beating industry growth in domestic formulation for two consecutive years, driven by product introductions and market share gains in existing products, adds the brokerage.
from NDTV Profit - Latest https://ift.tt/zXfwY7i
from NDTV Profit - Latest https://ift.tt/zXfwY7i
0 Response to "Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside"
Post a Comment